Full-Time
Scientist – Process Development
I, II, II
Posted on 6/18/2024
Cellares
51-200 employees
Develops and manufactures cell therapies efficiently
Compensation Overview
$90k - $210kAnnually
Entry
San Bruno, CA, USA
- Bachelor's, Master's or PhD in Bioengineering, Chemical Engineering, Biology, Biochemistry, or related field with 0-15 years of process development experience in the cell and gene therapy field
- Familiarity working on a GMP and/or Clinical Manufacturing setting strongly preferred
- Extensive experience designing scale-up experiments and troubleshooting semi-automated instruments
- Hands-on experience with both autologous and allogeneic cell therapy manufacturing processes
- Excellent verbal and written communication skills; able to interpret, summarize, and present scientific results in a clear, concise, accurate manner to both technical and non-technical audiences
- Experience with flow cytometry and cell based assays preferred
- Strong understanding of cell biology and immunology
- Creative, self-motivated, eager to take on a wide variety of tasks and grow with the evolving technology
- Design and execute complex experiments using scientific principles and statistical approaches (DOE) to support the development of the Cellares platform
- Interface internally and cross-functionally with Analytical Development, MSAT, Quality, Manufacturing, BD, Product, and Engineering to implement new processes and technologies as part of the core technology transfer team
- Author high-quality technical documents, procedures, and reports
- Analyze and present technical results at departmental meetings
- Perform routine laboratory activities including ordering, restocking, and equipment qualification/maintenance
- Gather and review system requirements, develop robust test plans, oversee and support execution of experiments
- Develop training materials for scientific methods and techniques, train and onboard new hires
- Serve as subject matter expert where appropriate for the cell and gene therapy process, provide technical insights and support in troubleshooting and root cause investigations
Cellares develops and manufactures cell therapies in the biotechnology sector, operating as an Integrated Development and Manufacturing Organization (IDMO) that combines these processes in one facility. Its proprietary "Smart Factory" technology features an automated single-use cartridge system, which increases productivity, reduces costs, and lowers process failure rates compared to traditional methods. The company serves a range of clients, including preclinical, clinical, and commercial entities, and has partnerships with major pharmaceutical companies for CAR-T cell therapy manufacturing. Cellares aims to provide efficient and cost-effective manufacturing services, distinguishing itself from competitors in the biotechnology industry.
Company Stage
Series C
Total Funding
$373M
Headquarters
South San Francisco, California
Founded
2019
6 month growth
↑ 20%1 year growth
↑ 35%2 year growth
↑ 95%
Simplify's Take
What believers are saying
- The $380M worldwide capacity reservation and supply agreement with Bristol Myers Squibb underscores Cellares' strong market position and growth potential.
- The launch of Cell Q, the world's first automated cGMP QC workcell, demonstrates Cellares' commitment to innovation and operational efficiency.
- The addition of industry veteran Christi Shaw to the advisory board brings invaluable expertise and leadership to the company.
What critics are saying
- The complexity of integrating advanced technologies like the Cell Shuttle and Cell Q could lead to operational challenges and delays.
- The highly competitive biotechnology sector requires continuous innovation to maintain a leading position, which can be resource-intensive.
What makes Cellares unique
- Cellares is the first Integrated Development and Manufacturing Organization (IDMO), combining development and manufacturing processes under one roof, unlike traditional CDMOs.
- Their proprietary 'Smart Factory' technology, including automated single-use cartridge systems, significantly boosts productivity and reduces costs and process failure rates.
- Strategic partnerships with major pharmaceutical companies like Bristol Myers Squibb and Lyell highlight their industry credibility and advanced capabilities.